A conference co-presented by the IBA Healthcare and Life Sciences Law Committee, the IBA Intellectual Property and Entertainment Law Committee and the IBA Technology Law Committee
Conference Co-Chairs
Özge Atilgan Karakulak Gün + Partners, Istanbul; Member, IBA Intellectual Property and Entertainment Law Committee Advisory Board
Yuval Horn Gornitzky, Tel Aviv
Alejandro Luna Olivares, Mexico City
Cécile Théard-Jallu De Gaulle Fleurance, Paris; Member, IBA Healthcare and Life Sciences Law Committee Advisory Board
Host Committee Co-Chairs
Francisco Brito e Abreu Uría Menéndez, Lisbon
Manuel Duraes Rocha Abreu Advogados, Lisbon; Chair, Food and Supplements Subcommittee, IBA Healthcare and Life Sciences Law Committee
Host Committee
Abreu Law
Cuatrecasas
GFDL Advogados
Gómez-Acebo & Pombo Abogados
Morais Leitão
Pérez-Llorca
PLMJ Advogados
SRS Legal
Uría Menéndez
VdA - Vieira de Almeida & Associados
Subjects include:
- Hot topic roundtables
- Beyond borders: rewriting the rules of global pharma patent litigation
- AI and data rights in life sciences/healthtech deals
- Clinical trials: current trends and perspectives at a global level
- Life sciences M&A in uncertain markets – earnouts, CVRs, contingent milestones, and IP-driven valuation mechanics/late-stage private financings and IPO alternatives (crossovers, structured preferred, PIPEs, ATMs and registered directs)
- What are the most challenging contractual issues when discussing licensing and other agreements with strategic partners?
- Preventive health and longevity: legal perspectives shaping the future of care
- Where will innovation go next? Global pharma strategies beyond the EU Pharmaceutical Package